The FDA's tight distribution and approval procedures limit the growth of the Generic Drugs Market. The FDA investigates the generic drugs' side effects, accuracy, and other components. The substance is recalled if a company disregards the rules. For instance, in October 2020 Sun Pharma recalled 747 bottles of a generic diabetic medication because they might have higher than allowed levels of the cancer-causing chemical nitrosodimethylamine.
The barrier to the global Generic Drugs Market is a lack of understanding of the generic medicine business. Drugs are inexpensive in developing nations, but the quality is limiting expansion. The generic medication sector is projected to have additional prospects in emerging economies like China and India.
